Luxna Biotech Co., Ltd. and Otolaryngology-Head and Neck Surgery, Tohoku University School of Medicine (Professor Yukio Katori, Headquarters:  Sendai-shi, Miyagi, Japan) announced that they have initiated the collaborative research to create antisense oligonucleotide that target a certain gene for the treatment of hearing loss. 

Please check here for details.